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anorectic effects (Rodriguez de Fonseca
et al., 2001) and leptin-independent hu-
moral effects on peripheral metabolism.
It is a peroxisome proliferator-activated
receptor-a (PPAR-a) ligand that requires
this nuclear receptor for its anorectic ac-
tion (Fu et al., 2003), but there is evidence
of neurotransmission via the transient po-
tential vanilloid-1 (TRPV-1) receptor
(Wang et al., 2005). TRPV-1 receptors
can be activated by temperature eleva-
tions (Chung et al., 2003), such as might
occur near UCP-1-expressing adipo-
cytes. Like leptin, they reduce hyperdo-
paminergia, a cause of hyperphagia
(Szczypka et al., 2000; Krugel et al.,
2003), which couldmean that they poten-
tiate leptin action. Finally, OEA-induced
PPAR-a activation in liver and muscle
could also account for the leptin-inde-
pendent, humorally induced, metabolic
improvement (Figure 1C).
While the mechanisms underlying the
effects observed by Yamada et al.
(2006) remain to be elucidated, the study
nevertheless clearly raises the possibility
that some white adipocytes possess the
equipment to regulate both caloric intake
and peripheral nutrient metabolism. If so,
identification of these factors involved
might lead to novel therapeutic interven-
tions to prevent the metabolic syndrome,
which now afflicts 39% of Americans
(Ford, 2005). In any case, at a clinical
level, a dominant role of fat tissue in
nutrient homeostasis is supported by
the fact that patients without adipocytes
(congenital generalized lipodystrophy)
develop both hyperphagia and severe
metabolic syndrome and that both re-
spond to leptin replacement therapy
(Oral et al., 2002) with significant im-
provement.
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P R E V I E W SPancreatic b cells:
Responding to the matrix
In a recent issue of Developmental Cell, Nikolova et al. (2006) make the unusual discovery that, unlike most epithelial cells,
pancreatic b cells do not produce a basement membrane of extracellular matrix. Rather, the matrix is provided to a subset of
b cells by local capillary endothelial cells, explaining in part how the endothelium helps promote optimal levels of insulin
production.Endocrine cells must sense molecules in
the bloodstream and secrete others in
response, all of which is enabled by prox-
imity to the vasculature. Establishing
and maintaining appropriate interactions
with the endothelium are therefore cru-
cial for endocrine gland function. Such
interactions are likely to be specific for
different tissues: consider the fine capil-
laries in a pancreatic islet compared to
the large, hepatic sinusoidal endothe-
lium. Indeed, certain endocrine cells pro-
mote local vascular development by
secreting one of the common vascular
endothelial growth factors (VEGFs) (Lam-
mert et al., 2003), while other endocrine148cells elaborate a specific VEGF variant
(LeCouter et al., 2001). Less clear is
how endothelial cells may signal back
to endocrine cells independently of the
bloodstream, e.g., to promote the endo-
crine differentiation or to elicit proper in-
teractions with the endothelium. Such
signaling may be relevant to therapies
for diabetics because transplanted islets
take a week or so to revascularize (Jans-
son and Carlsson, 2002), which in the in-
terim could affect insulin-producing b cell
integrity and function. In a recent issue of
Developmental Cell, Lammert and col-
leagues (Nikolova et al., 2006) advance
the field by investigating the role of theextracellular matrix produced by endo-
thelial cells in the functions of pancreatic
b-endocrine cells.
The extracellular matrix (ECM) con-
sists of a meshwork of proteins that re-
side outside of cells. For epithelial cells
with apical (secretory) and basal sur-
faces, the basal ECM defines the ‘‘base-
ment membrane,’’ which provides an
adherent substratum and promotes cell
differentiation. Most epithelial cells pro-
duce, or are capable of producing, their
own basement membrane. Disruption
of the epithelial basement membrane oc-
curs during organogenesis, tissue regen-
eration, and tumorigenesis, and thus theCELL METABOLISM : MARCH 2006
P R E V I E W Sexpression and function of basal ECM
proteins has been studied intensely.
Nikolova et al. made an unusual dis-
covery: They found that b cells within
the mouse pancreatic islet appear not
to produce their own basement mem-
brane ECM proteins. Rather, they found
that capillary endothelial cells within the
islet produce their own basement mem-
brane ECM proteins and present them
to the nearby b cells. This raised the
question of whether the endothelial ECM
helps promote b cell function.
Mice that were genetically depleted of
islet capillaries exhibited lower levels of
insulin mRNA and fewer insulin secretory
granules. These findings agree with de-
velopmental studies showing that a vas-
culature is necessary for the initial induc-
tion of insulin in embryos (Lammert et al.,
2001; Yoshitomi and Zaret, 2004). How-
ever, the findings could have been due
to a diminished blood supply rather
than the absence of the endothelium or
the endothelial ECM. The present au-
thors then went to great lengths to as-
sess the ability of purified ECM proteins,
normally produced by the capillary endo-
thelium, to stimulate insulin mRNA in
pancreatic islets isolated from capillary-
depleted animals and in an insulinoma
cell line. In these in vitro assays, the pres-
ence of ECM proteins, particularly cer-
tain laminins, enhanced insulin mRNA
expression by up to 2-fold. This could
help explain the authors’ previous obser-
vation that the absence of islet capillaries
impairs the rapidity of the response to
a glucose challenge (Lammert et al.,
2003). However, the animals in that study
were not diabetic, implying that vessels
remaining near the islets, in the islet cap-
illary depletion model, were sufficient to
allow glucose regulation and that capil-
lary endothelial ECM has only a partial
effect on supporting b cell differentiation.
That the three-dimensional environ-
ment of the matrix would help support
differentiation rather than determine it
absolutely is consistent with many other
studies (Cukierman et al., 2002). Some
differentiation effects of the matrix can
be secondary. A key aspect of a primary
response to the matrix is whether the ef-
fect of an ECM protein is mediated by
binding to an integrin, which are signaling
receptors in the plasma membrane. Ni-
kolova et al. investigated this parameter
with function-blocking integrin antibodies
and siRNA knockdowns and showed
that, indeed, the b1 integrin subunit isCELL METABOLISM : MARCH 2006Figure 1. Pancreatic islet microvasculature
The figure depicts an idealized section of a pancreatic islet, where the insulin-producing b cells surround a cap-
illary endothelial cell. The islet capillaries produce extracellular matrix proteins that constitute a ‘‘basement
membrane,’’ whereas the b cells do not. The b cells express integrin-type receptors for the basement mem-
brane matrix proteins. Such receptors containing the b1 subunit help the b cells sense the matrix and contrib-
ute, in as yet undetermined ways, to the maintenance of high levels of insulin production. By such means,
capillary endothelial cells signal to the b cells.crucial for the stimulatory effect
of endothelial ECM proteins on insulin
mRNA expression. These data imply
that integrin-based signal transduction
must be considered part of the b cell net-
work for proper insulin production and
underscore the importance of using
a proper ECM substratum for attempts
to differentiate stem cells to a b cell phe-
notype.
The authors also observed that expo-
sure to endothelial ECM proteins was
associated with a 2%–4% increase in
the number of insulinoma cells and islet
cells traversing through S phase. This
seems marginal, suggesting that the
previously observed correlation of b cell
mass with vascular density may be pri-
marily an effect of oxygenation and
blood factors (Duvillie et al., 2002; Inoue
et al., 2002).
Once again, the ability to demonstrate
direct signaling from endothelial cells,
apart from the circulation, is an essential
point in this field. Simple genetic dem-
onstration of the necessity of the vas-
culature in vivo is insufficient. By recon-
stituting endothelial matrix proteins withcapillary-deficient islets or a b cell line,
Nikolova et al. provide a mechanistic
basis for direct endothelial signaling to
b cells in their local environment (Fig-
ure 1). Given the emergence of diverse
examples of endothelial cells as signaling
sources (Carmeliet, 2003; Cleaver and
Melton, 2003), it seems likely that the
ECM will be one of several means for
endothelial cells to participate in the re-
ciprocal signaling that promotes devel-
opment, maintains tissue homeostasis,
and can be perturbed in disease.
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logia 45, 749–763.Coming up for air:
HIF-1 and mitochondr
Hypoxic cells induce glycolytic enzymes;
produces glycolytic ATP. Two papers in th
that HIF-1 also influences mitochondrial f
hydrogenase kinase 1 (PDK1). PDK1 regu
Oxygen deprivation (hypoxia) occurs in
tissues when O2 supply via the car-
diovascular system fails to meet the de-
mand of O2-consuming cells. Hypoxia
occurs naturally in physiological settings
(e.g., embryonic development and exer-
cising muscle), as well as in pathophysi-
ological conditions (e.g., myocardial in-
farction, inflammation, and solid tumor
formation). For over a century, it has
been appreciated that O2-deprived cells
exhibit increased conversion of glucose
to lactate (the ‘‘Pasteur effect’’). Activa-
tion of the Pasteur effect during hypoxia
in mammalian cells is facilitated by
HIF-1, which mediates the upregulation
of glycolytic enzymes that support an in-
crease in glycolytic ATP production as
mitochondria become starved for O2,
the substrate for oxidative phosphoryla-
tion (Seagroves et al., 2001). Thus, mito-
chondrial respiration passively decreases
due to O2 depletion in hypoxic tissues.
However, reports by Kim et al. (2006)
and Papandreou et al. (2006) in this issue
of Cell Metabolism demonstrate that this
critical metabolic adaptation is more
complex and includes an active suppres-
sion of mitochondrial pyruvate catabo-
lism and O2 consumption by HIF-1.
Mitochondrial oxidative phosphoryla-
tion is regulated by multiple mecha-
nisms, including substrate availability.
Major substrates include O2 (the terminal
electron acceptor) and pyruvate (the pri-
mary carbon source). Pyruvate, as the
end product of glycolysis, is converted
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Nature 412, 877–884.ial oxygen consumpti
this HIF-1-mediated metabolic adaptation
is issue of Cell Metabolism (Kim et al., 200
unction, suppressing both the TCA cycle
lation in hypoxic cells promotes cell surv
to acetyl-CoA by the pyruvate dehydro-
genase enzymatic complex and enters
the tricarboxylic acid (TCA) cycle. Pyru-
vate conversion into acetyl-CoA is irre-
versible; this therefore represents an im-
portant regulatory point in cellular energy
metabolism. Pyruvate dehydrogenase
kinase (PDK) inhibits pyruvate dehydro-
genase activity by phosphorylating its
E1 subunit (Sugden and Holness, 2003).
In the manuscripts by Kim et al. (2006)
and Papandreou et al. (2006), the authors
find that PDK1 is a HIF-1 target gene that
actively regulates mitochondrial respira-
tion by limiting pyruvate entry into the
TCA cycle. By excluding pyruvate from
mitochondrial metabolism, hypoxic cells
accumulate pyruvate, which is then con-
verted into lactate via lactate dehydroge-
nase (LDH), another HIF-1-regulated en-
zyme. Lactate in turn is released into the
extracellular space, regenerating NAD+
for continued glycolysis by O2-starved
cells (see Figure 1). This HIF-1-depen-
dent block to mitochondrial O2 con-
sumption promotes cell survival, espe-
cially when O2 deprivation is severe and
prolonged.
Papandreou et al. demonstrate that
hypoxic regulation of PDK has important
implications for antitumor therapies. Re-
cent interest has focused on cytotoxins
that target hypoxic cells in tumor micro-
environments, such as the drug tirapaz-
amine (TPZ). Because intracellular O2
concentrations are decreased by mito-
chondrial O2 consumption, HIF-1 couldNikolova, G., Jabs, N., Konstantinova, I., Domo-
gatskaya, A., Tryggvason, K., Sorokin, L., Fass-
ler, R., Gu, G., Gerber, H.-P., Ferrara, N., et al.
(2006). Dev. Cell, in press.
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ment 131, 807–817.
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increases glucose flux to pyruvate and
6; Papandreou et al., 2006) demonstrate
and respiration by inducing pyruvate de-
ival.
protect tumor cells from TPZ-mediated
cell death by maintaining intracellular O2
levels. Indeed, Papandreou et al. show
that HIF-1-deficient cells grown at 2%
O2 exhibit increased sensitivity to TPZ
relative to wild-type cells, presumably
due to higher rates of mitochondrial O2
consumption. HIF-1 inhibition in hypoxic
tumor cells should have multiple thera-
peutic benefits, but the use of HIF-1 in-
hibitors in conjunction with other treat-
ments has to be carefully evaluated for
the most effective combination and se-
quence of drug delivery. One result of
HIF-1 inhibition would be a relative de-
crease in intracellular O2 levels, making
hypoxic cytotoxins such as TPZ more
potent antitumor agents. Because PDK
expression has been detected in multiple
human tumor samples and appears to be
induced by hypoxia (Koukourakis et al.,
2005), small molecule inhibitors of HIF-1
combined with TPZ represent an attrac-
tive therapeutic approach for future clini-
cal studies.
Hypoxic regulation of PDK1 has other
important implications for cell survival
duringO2depletion.Because theTCAcy-
cle is coupled to electron transport, Kim
et al. suggest that induction of the pyru-
vate dehydrogenase complex by PDK1
attenuates not only mitochondrial respi-
ration but also the production of mito-
chondrial reactive oxygen species (ROS)
in hypoxic cells. ROS are a byproduct
of electron transfer to O2, and cells cul-
tured at 1 to 5% O2 generate increased
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